Table 1 Patient Characteristics of target dataset (N = 61).
Variables | N (%) | |
---|---|---|
Age (Year) | ≤45 | 32 (52.5%) |
>45 | 29 (47.5%) | |
Major Complication | No | 51 (83.6%) |
Yes | 10 (16.4%) | |
Mastectomy | Total/radical | 39 (64.0%) |
Nipple-sparing | 16 (26.2%) | |
Skin-sparing | 6 (9.8%) | |
Type of reconstruction | Autologous | 47 (77.0%) |
Tissue Expander | 14 (23.0%) | |
RT fractionation | Conventional | 53 (86.9%) |
Hypofractionated | 8 (13.1%) | |
Neoadjuvant chemotherapy | No | 43 (70.5%) |
Yes | 18 (29.5%) | |
Adjuvant chemotherapy | No | 21 (34.4%) |
Yes | 39 (63.9%) | |
Missing | 1 (1.6%) | |
RT plan | 3D | 48 (78.7%) |
IMRT | 13 (21.3%) | |
Tumor bed boost | No | 49 (80.3%) |
Yes | 12 (19.7%) | |
The use of bolus | No | 59 (96.7%) |
Yes | 2 (3.3%) | |
Body mass index (kg/m2) | ≤23 | 32 (52.5%) |
>23 | 29 (47.5%) | |
Pre-RT CT to Post-1Y CT (days) | 417 (IQR 343–512) | |
Pre-RT CT to Post-2Y CT (days) | 803 (IQR 741–951) | |
Pre-RT Anomaly score | 1.99 (range, −0.65 to 19.40) | |
Post-1Y Anomaly score | 2.92 (range, −0.16 to 11.50) | |
Post-2Y Anomaly score | 2.94 (range, −0.36 to 14.35) |